Evidence map›Paper›PMID 22982815›Full record

ReviewBiochimica et biophysica acta2013

Integrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactions.

Abby L Parrill, Gabor Tigyi

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Lysophosphatidic acid (LPA) as a modulator of plasma membrane CaJournal of physiology and biochemistry · 2021
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abby L ParrillDepartment of Chemistry, The University of Memphis, Memphis, TN 38152, USA. aparrill@memphis.edu
Gabor Tigyi

Funding

Ligand Recognition by Phospholipid Growth Factor ReceptorsR01CA092160 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI TIGYI, GABOR J · 2001 to 2022
$5.9M
Computational Approach to Ligand Discovery for LPA GPCR and PPARR01HL084007 · NHLBI · UNIVERSITY OF MEMPHIS · PI PARRILL, ABBY L. · 2006 to 2010
$2.1M
Analysis of Radiomitigative Cell SignalingR01AI080405 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI TIGYI, GABOR J · 2008 to 2012
$2.1M
Novel Radiomitigators Targeting LPA ReceptorsI01BX001187 · VA · MEMPHIS VA MEDICAL CENTER · PI TIGYI, GABOR J · 2013 to 2016
–
BLRD VA I01 BX001187NCI NIH HHS CA092160NCI NIH HHS R01 CA092160NHLBI NIH HHS HL084003NHLBI NIH HHS R01 HL084007NIAID NIH HHS AI80405NIAID NIH HHS R01 AI080405
6 · The paper itself

Abstract

A compelling question of how phospholipids interact with their target receptors has been of interest since the first receptor-mediated effects were reported. The recent report of a crystal structure for the S1P(1) receptor in complex with an antagonist phospholipid provides interesting perspective on the insights that had previously been gained through structure-activity studies of the phospholipids, as well as modeling and mutagenesis studies of the receptors. This review integrates these varied lines of investigation in the context of their various contributions to our current understanding of phospholipid-receptor interactions. This article is part of a Special Issue entitled Advances in Lysophospholipid Research.

Indexed as

Amino Acid SequenceAnimalsHumansMolecular Sequence DataPhospholipidsReceptors, G-Protein-CoupledReceptors, Lysophosphatidic AcidReceptors, LysosphingolipidSignal TransductionStructure-Activity RelationshipPhospholipidsReceptors, G-Protein-CoupledReceptors, Lysophosphatidic AcidReceptors, Lysosphingolipid

Identifiers

PMID22982815
PMCPMC3591812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.